Compare AGRZ & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AGRZ | EVAX |
|---|---|---|
| Founded | 2020 | 2008 |
| Country | Malaysia | Denmark |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.3M | 42.7M |
| IPO Year | 2025 | 2021 |
| Metric | AGRZ | EVAX |
|---|---|---|
| Price | $0.43 | $4.03 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $12.33 |
| AVG Volume (30 Days) | ★ 373.1K | 65.9K |
| Earning Date | 02-10-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2038.10 | N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $14,879,848.00 | $7,650,000.00 |
| Revenue This Year | N/A | $128.77 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $4.30 | ★ N/A |
| Revenue Growth | ★ 200.67 | 132.17 |
| 52 Week Low | $0.42 | $1.20 |
| 52 Week High | $7.20 | $12.15 |
| Indicator | AGRZ | EVAX |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 33.45 |
| Support Level | N/A | $4.11 |
| Resistance Level | N/A | $4.85 |
| Average True Range (ATR) | 0.00 | 0.38 |
| MACD | 0.00 | -0.08 |
| Stochastic Oscillator | 0.00 | 8.23 |
Agroz Inc is a vertically integrated agricultural technology (AgTech) company focused on designing, innovating, developing, building, operating and managing large, commercial-scale, industrial-grade indoor CEA vertical farms using CEA practices. Its mission is to improve food safety, food security, and sustainability for society by creating a reliable, accessible food supply through its AgTech products and services. CEA vertical farming is an agricultural method involving crop cultivation through vertically stacked layers in a controlled indoor environment. CEA practices are defined by growing produce in spaces where environmental conditions can be controlled and manipulated to match the needs of specific plants.
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.